Please login to the form below

Immuno-oncology: The market opportunity for PD-1/PD-L1s


Immuno-oncology is the new frontier in cancer treatment. Using the body’s own immune system to treat cancer, new therapies are producing impressive survival benefits, with reduced side effects. Of these therapies, immune checkpoint inhibitors are showing particular promise.Our latest infographic is a snapshot of the PD-1/PD-L1 market at this time.

http://www.researchpartnership.com/news/2016/08/infographic-immunno-oncology/

23rd November 2016

Share

Tags

Company Details

Research Partnership

+44 (0)20 8069 5000

Contact Website

Address:
Chester House
Fulham Green
81-83 Fulham High Street
London
SW6 3JW
United Kingdom

Latest content on this profile

Live from Singapore: Exploring the opportunity for women’s health in emerging markets
Join global healthcare market research consultants Pei Li Teh and Wan Ling Neo for this complimentary webinar in which they will explore the opportunity for women’s health in emerging markets.
Research Partnership
Men vs Women in emerging markets
Our latest interactive infographic compares male vs female health characteristics in the BRIC emerging marketS
Research Partnership
South Korea: The next global player?

Research Partnership
20 questions: Round 4

Research Partnership
Will gene therapies finally be commercially viable to pharma?

Research Partnership
Wargaming in HCV

Research Partnership